ASPIRINA trade mark attributed by Bayer to acetylsalicylic acid; a pharmaceutical product with multiple indications; including the care of "women's disorders". Despite the broad spectrum of action; the announcement in this case is aimed only at the female target. Since its inception in 1899; the pharmaceutical company had to defend the brand from the competition's products; as is apparent from the announcement; and at the end of the First World War lost the right to use the name; which a 1921 US judgment rendered in public domain In almost all nations; with few exceptions such as Italy and Canada. Press Release; Italy 1930